Can you invest in MindMed?

For those with higher risk tolerances and extremely long time horizons, MindMed is a company to consider investing in.

Is MindMed on Nasdaq?

MindMed will commence trading on the Nasdaq under the symbol MNMD effective April 27, 2021; until then the Company will continue to trade in the United States under the symbol MMEDF on the OTCQB.

How much is MMEDF trading for?

– NASDAQ:MMEDF – Stock Quote & News – TheStreet.

Mind Medicine (MindMed), Inc. (MMEDF)
Prev Close2.19
52 Wk Low/High1.05 / 5.77

Is MMEDF a good stock to buy?

Our proprietary rating system also evaluates each stock based on eight different categories. MMEDF has a Value Grade of C. Its trailing-12-months Price/Book ratio of 17.27x, which is 271.1% higher than the 4.65x industry average, justifies the grade. … MMEDF is ranked #226 of 491 stocks in the F-rated Biotech industry.

How many shares of MindMed are there?

(MMED.NE) Valuation Measures & Financial Statistics.

Share Statistics.
Avg Vol (3 month) 3524.68k
Shares Outstanding 5420.74M
Implied Shares Outstanding 6421.2M
Float 8370.91M
% Held by Insiders 115.72%

Will Mmedf become Mnmd?

As a reminder, MindMed will retain its listing on the Neo Exchange Inc. under the symbol “MMED”. Once trading begins, the Company’s subordinate voting shares will convert from the OTCQB under the symbol “MMEDF” to the new symbol “MNMD”.

Is MindMed overvalued?

MindMed (NASDAQ:MNMD) is a neuro-pharmaceutical company that specializes in psychedelic medicine. It discovers, develops and deploys these products to improve health, promote wellness and alleviate suffering.

Why is MindMed stock going down?

MindMed stock fell Thursday after the psychedelic drug developer said a Swiss ethics committee cleared the company to begin a study on the effects of the hallucinogen mescaline. The study, set to start this month, adds to the research MindMed (MNMD) is conducting on other psychedelic drugs.

What happened to Mmedf stock?

MMEDF stock is still trading today, but on Tuesday, the stock’s ticker for U.S. investors will change to MNMD. Trading of the stock will continue on the Neo Exchange for German and Canadian traders under the ticker MMED. The listing capitalizes on the growing interest in psilocybin mushrooms.